X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (71) 71
index medicus (53) 53
urology & nephrology (49) 49
cancer (46) 46
male (44) 44
urology (44) 44
middle aged (41) 41
aged (37) 37
female (35) 35
prognosis (28) 28
oncology (25) 25
retrospective studies (23) 23
bladder cancer (21) 21
surgery (21) 21
adult (20) 20
life sciences (20) 20
tumors (20) 20
urinary bladder neoplasms - pathology (19) 19
analysis (18) 18
prostate cancer (18) 18
neoplasm staging (16) 16
transplantation (15) 15
aged, 80 and over (14) 14
medicine & public health (13) 13
risk (13) 13
risk factors (13) 13
treatment outcome (13) 13
diagnosis (12) 12
urinary bladder neoplasms - surgery (12) 12
kidney (11) 11
pathology (11) 11
prostatectomy (11) 11
research (11) 11
transitional-cell carcinoma (11) 11
urothelial carcinoma (11) 11
carcinoma (10) 10
human health and pathology (10) 10
kidney neoplasms - pathology (10) 10
survival (10) 10
cystectomy (9) 9
follow-up studies (9) 9
france (9) 9
france - epidemiology (9) 9
renal transplantation (9) 9
testosterone (9) 9
urinary bladder neoplasms - mortality (9) 9
[ sdv.can ] life sciences [q-bio]/cancer (8) 8
[sdv.can]life sciences [q-bio]/cancer (8) 8
biopsy (8) 8
carcinoma, transitional cell - pathology (8) 8
cell carcinoma (8) 8
immunology (8) 8
kidney transplantation (8) 8
metastasis (8) 8
neoplasm invasiveness (8) 8
oncology, experimental (8) 8
survival rate (8) 8
treatment (8) 8
urology and nephrology (8) 8
[ sdv.mhep.un ] life sciences [q-bio]/human health and pathology/urology and nephrology (7) 7
chemotherapy (7) 7
disease-free survival (7) 7
kaplan-meier estimate (7) 7
kidney neoplasms - surgery (7) 7
mesh : humans (7) 7
multivariate analysis (7) 7
neoplasm recurrence, local - pathology (7) 7
nephrectomy (7) 7
prevalence (7) 7
prostatic neoplasms - surgery (7) 7
renal cell carcinoma (7) 7
urinary bladder neoplasms - therapy (7) 7
[sdv.mhep.un]life sciences [q-bio]/human health and pathology/urology and nephrology (6) 6
bacillus-calmette-guerin (6) 6
carcinoma, transitional cell - mortality (6) 6
carcinoma, transitional cell - surgery (6) 6
care and treatment (6) 6
epidemiology (6) 6
mesh: humans (6) 6
metastases (6) 6
neoplasm grading (6) 6
patients (6) 6
prospective studies (6) 6
prostatic neoplasms - pathology (6) 6
radical cystectomy (6) 6
surgical oncology (6) 6
surveys and questionnaires (6) 6
urinary bladder neoplasms (6) 6
urinary bladder neoplasms - genetics (6) 6
bcg vaccine - therapeutic use (5) 5
bladder (5) 5
breast-cancer (5) 5
carcinoma, renal cell (5) 5
carcinoma, renal cell - pathology (5) 5
classification (5) 5
comparative analysis (5) 5
cystectomy - methods (5) 5
immunotherapy (5) 5
invasiveness (5) 5
men (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 676 - 685
Journal Article
La Revue du praticien, ISSN 0035-2640, 12/2014, Volume 64, Issue 10, pp. 1367 - 1368
Journal Article
World Journal of Urology, ISSN 0724-4983, 11/2018, Volume 36, Issue 11, pp. 1727 - 1740
Over the past 3 decades, no major treatment breakthrough has been reported for advanced bladder cancer. Recent Food and Drug Administration (FDA) approval of... 
Urothelial cancer | Nephrology | Medicine & Public Health | Immunotherapy | PD-L1 | Oncology | Immune checkpoint inhibitors | CTLA-4 | Bladder cancer | PD-1 | Urology | MULTICENTER | METASTATIC UROTHELIAL CARCINOMA | ATEZOLIZUMAB | SINGLE-ARM | SYSTEMIC THERAPY | CHEMOTHERAPY | PHASE-III TRIAL | PEMBROLIZUMAB | CISPLATIN-INELIGIBLE PATIENTS | UROLOGY & NEPHROLOGY | RADIOTHERAPY | Biomarkers - metabolism | Carcinoma, Transitional Cell - mortality | Immunotherapy - methods | Urinary Bladder Neoplasms - mortality | Prognosis | Risk Assessment | CTLA-4 Antigen - drug effects | Humans | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | Male | Treatment Outcome | Carcinoma, Transitional Cell - therapy | Molecular Targeted Therapy | Disease-Free Survival | Carcinoma, Transitional Cell - pathology | Urinary Bladder Neoplasms - therapy | Survival Analysis | Urinary Bladder Neoplasms - pathology | Female | Programmed Cell Death 1 Receptor - drug effects | Immunologic Factors - therapeutic use | PD-1 protein | Invasiveness | Clinical trials | Metastasis | FDA approval | Patients | Cisplatin | Immunosuppressive agents | Metastases | CTLA-4 protein | Pembrolizumab | Immune checkpoint | PD-L1 protein | Monoclonal antibodies | Urothelial carcinoma | Tumors | Immunologic Factors | Carcinoma, Transitional Cell | Urinary Bladder Neoplasms | CTLA-4 Antigen | Life Sciences | Human health and pathology | Biomarkers | Programmed Cell Death 1 Receptor | Cancer
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 462 - 475
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2010, Volume 183, Issue 4, pp. e367 - e367
Journal Article
European Journal of Cancer, ISSN 0959-8049, 02/2019, Volume 108, pp. 111 - 119
Assessment of tumour-infiltrating lymphocytes (TILs) can provide important prognostic information in various cancers and may be of value in predicting response... 
Prognosis | Tumour lymphocyte infiltration | Bladder cancer | T1G3 | PROSTATE | SURVIVAL | IMPACT | IMMUNE CONTEXTURE | ONCOLOGY | CLASSIFICATION | EXPRESSION | CELL-CARCINOMA | T cells | Analysis | Tumors | Paraffins | Immune response | Risk groups | Invasiveness | Muscles | Bladder | Data processing | Lymphocytes T | Histology | Inflammation | Paraffin | Patients | Survival | Density | Metastases | Confidence intervals | Lymphocytes B | Lymphocytes | Immunotherapy | Infiltration | Cancer | Immune system
Journal Article
PLOS ONE, ISSN 1932-6203, 02/2019, Volume 14, Issue 2, p. e0211721
Aim To assess the prognostic value of multiple recurrences on the risk of progression in a large cohort of TaG1 bladder cancer of low and intermediate risk... 
FOLLOW-UP | IMPACT | BACILLUS-CALMETTE-GUERIN | FGFR3 | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | Medicine, Experimental | Medical research | Cancer patients | Health aspects | Bladder cancer | Analysis
Journal Article
Journal Article
Journal Article
The Journal of Urology, ISSN 0022-5347, 04/2018, Volume 199, Issue 4, pp. e615 - e616
Journal Article
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 253 - 12
The upregulation of PPAR gamma/RXR alpha transcriptional activity has emerged as a key event in luminal bladder tumors. It renders tumor cell growth PPAR... 
COMPLEX | LIGAND-BINDING | PROTEIN | COMPREHENSIVE MOLECULAR CHARACTERIZATION | MULTIDISCIPLINARY SCIENCES | DYNAMICS | RECEPTOR | REVEALS | BASAL | Pathogenicity | Pathogens | Reactive oxygen species | TLR7 protein | Oxidase | CYBB protein | Toll-like receptors | Viruses | Infections | Life Sciences | Human health and pathology | Urology and Nephrology | Biochemistry, Molecular Biology | Genomics | Cancer
Journal Article